Why Medicare Lead Buying Is Riskier Right Now

The Medicare lead market is offering its biggest opportunity in years — and its biggest trap. The same disruption driving demand is also drawing unprecedented regulatory attention, and agents who buy carelessly are paying for it.

According to ATI Advisory's market analysis, roughly 7% of Medicare Advantage enrollees — about 2 million beneficiaries — need new coverage for PY2025 because their plans terminated or exited their counties. In a typical year, fewer than 2% of enrollees face this situation. That surge of displaced beneficiaries is why lead demand has spiked.

But the opportunity arrives with real risk. Industry compliance guidance is blunt: CMS is cracking down on Medicare advertising, and agents must keep marketing straightforward, honest, and accurate. A lead bought from a vendor with sloppy sourcing can expose you to serious consequences:

• TCPA violations from calls or texts to contacts who never gave proper consent
• Carrier penalties when improper lead sourcing traces back to your contract
• Regulatory scrutiny that follows you well beyond a single campaign
• Wasted agent hours chasing leads that were never legitimately interested

William DeCourcy, Chief Lead Generation Officer at AmeriLife, put it plainly in an InsuranceNewsNet interview: "Bad leads cost more than just the price of the lead itself." His advice — "Your growth strategy shouldn't outpace your compliance strategy" — captures the tension agents face this season.

The financial backdrop raises the stakes further. Carrier financial data from Q3 2025 shows combined operating margins falling from +3.9% to –1.1% year over year, a 500 basis point decline, while Medical Loss Ratios climbed to 91.8%. Carriers under margin pressure have little tolerance for compliance missteps from the agents and vendors in their distribution chains.

This is why consent documentation matters as much as lead price. Before any outreach campaign runs, the lead's source and permission records need to be verified — a discipline we apply at My AI Call Center, where lists without clear permission records are flagged and, in most cases, declined before a single call goes out.

DeCourcy recommends focusing on cost per acquisition rather than cost per lead, because the true cost of a lead includes everything that happens after you buy it. A cheap lead with no consent trail is the most expensive lead on the market.

What Actually Makes a Medicare Lead Vendor 'the Best'

Here's an uncomfortable truth: no credible industry source publishes head-to-head rankings of Medicare lead vendors. The research doesn't name a single "best" vendor — it names something more useful. It describes the criteria that separate lead partners worth your budget from the ones that quietly create regulatory exposure.

The first criterion is transparent lead sourcing and consent documentation. William DeCourcy, Chief Lead Generation Officer at AmeriLife, warns that "bad leads cost more than just the price of the lead itself," and advises due diligence into vendor sourcing methods, opt-in processes, and data privacy protocols before you spend a dollar (InsuranceNewsNet reports). Improperly sourced leads invite TCPA violations, carrier penalties, and regulatory scrutiny — costs that dwarf the sticker price.

Second, look for compliance training and support, not just lead delivery. CMS is "cracking down on Medicare advertising," so marketing must stay straightforward, honest, and accurate (Quotit's compliance guidance notes). Pinnacle Financial Services models this approach: "we provide our agents with training and guidance they need to remain compliant throughout their promotional efforts" (Pinnacle's lead-generation analysis). A vendor that leaves you alone after the list ships is a liability.

Third, demand multi-channel capability. Digital channels matter — seniors are more tech-savvy than ever — but traditional channels still pull weight. Healthcare-related direct mail earns a ~4.09% response rate per Association of National Advertisers benchmarks (Pinnacle's data), and 83% of Nielsen respondents trust recommendations from friends and family. Vendors that diversify across channels mitigate risk and widen reach.

Fourth, measure cost per acquisition, not cost per lead. DeCourcy puts it plainly: "I relentlessly focus on this number" — CPA, not CPL, reveals true lead source efficiency (InsuranceNewsNet). A $5,000 spend yielding 10 closed deals means a $500 CPA; that's the number that tells you if a vendor works.

Finally, target the disruption window. 7% of MA enrollees — roughly 2 million beneficiaries — need new coverage for PY2025 due to plan terminations or county exits, versus under 2% in a typical year (ATI Advisory's market analysis). Vendors who can identify and reach these displaced beneficiaries convert better than generic list sellers.

In short, the best vendor is the one that answers these questions before you ask them. A partner like My AI Call Center applies the same discipline — reviewing list source and consent records before any campaign launches, and telling you plainly if a list won't support the goal.

Measure Vendors by Cost Per Acquisition, Not Cost Per Lead

The cheapest lead on the market can quietly become the most expensive one you buy. William DeCourcy, Chief Lead Generation Officer at AmeriLife and founder of LeadStar, puts it plainly: "I relentlessly focus on this number [cost per acquisition]" — not the sticker price of the lead itself.

Cost per lead (CPL) tells you what you paid. Cost per acquisition (CPA) tells you what you earned. The math is simple: spend $5,000 on leads that yield 10 closed deals, and your true CPA is $500, as industry guidance on Medicare lead buying illustrates. A vendor charging twice as much per lead but converting at three times the rate wins every time.

The margin math makes this non-negotiable. According to Q3 2025 carrier financials, the combined operating margin across major Medicare carriers fell from +3.9% to –1.1% in a single year, while Medical Loss Ratios climbed to 91.8%. As analysts Jared Strock and Teya Trujillo note, "margin recovery is proving elusive" even with double-digit revenue growth. Downstream, that pressure lands on agents and the vendors who supply them.

Cheap leads carry a second, hidden cost: compliance exposure. DeCourcy warns that "bad leads cost more than just the price of the lead itself," because improperly sourced leads raise TCPA risks, carrier penalties, and regulatory scrutiny. With CMS cracking down on Medicare advertising, a lead without a clean consent record can trigger consequences far beyond the purchase price.

When evaluating vendors, demand proof before you spend:

• Documented consent records and lead sourcing transparency for every contact
• CPA performance data, not just CPL pricing sheets
• A compliance track record aligned with FTC and CMS standards
• Follow-up processes that protect the lead's validity after delivery

This is the same discipline My AI Call Center applies to its own campaigns: list source and consent records are checked before launch, and lists without clear permission records are flagged or declined. Wasted spend on unworkable lists is prevented before it happens.

The market context sharpens the stakes. With 7% of Medicare Advantage enrollees — roughly 2 million beneficiaries — needing new coverage for PY2025, the opportunity is real, but so is the competition. Every dollar spent on a lead that can't legally be called, or won't convert, is a dollar your competitor spends on one that will.

Judge vendors on what a lead actually produces. The number that matters is the one at the end of the funnel, not the one on the invoice.

The Follow-Up Layer Most Vendors Ignore

Buying a Medicare lead is only the first step—what happens after purchase determines whether that contact becomes an appointment or a compliance risk. Speed-to-lead follow-up is critical: research shows that contacting a lead within minutes dramatically increases conversion potential, yet many vendors deliver leads without any follow-up structure, leaving agents to chase cold contacts during inconvenient hours. Calling within approved TCPA windows, honoring opt-outs and DNC requests immediately, and providing clear AI disclosure on every outbound call are non-negotiable requirements that protect both conversion rates and regulatory standing.

A structured, consent-checked calling process transforms raw leads into qualified opportunities by enforcing discipline at every stage. My AI Call Center manages campaigns that only contact approved, permissioned, or reviewed lists—verifying consent records and list sources before any call is made. Campaigns are scoped around one clear outcome, such as lead qualification or appointment setting, with scripts, disclosures, and opt-out handling approved in advance. Outcomes are routed back into your CRM with disposition codes (confirmed, qualified, opted out, no answer), per-call notes, and follow-up requests, ensuring transparency and accountability.

This layer is where lead quality meets operational execution. With 7% of MA enrollees (approximately 2 million beneficiaries) needing new coverage for PY2025 due to plan terminations or county exits, the window for effective engagement is narrow and compliance-sensitive. Agents who prioritize cost-per-acquisition over cost-per-lead understand that bad leads waste more than just the purchase price—they risk TCPA violations, carrier penalties, and eroded trust. A managed calling service that enforces list discipline, honors DNC logs in real time, and reports only what actually happened—without inventing metrics or testimonials—provides the qualifying layer that turns raw leads into appointments while keeping compliance intact.

• Speed-to-lead follow-up called within minutes inside approved TCPA windows
• AI disclosure on every call, with keyword opt-outs (STOP, REVOKE) honored immediately
• DNC requests respected across campaigns and carried into client DNC records
• Outcomes routed back to CRM with disposition codes and per-call notes
• Rate locked at 9¢ per connected minute, with setup and management fees quoted before launch

Your Vendor Evaluation Checklist Before You Spend a Dollar

The cheapest lead on the market can end up being the most expensive decision you make all year. As AmeriLife's William DeCourcy puts it, "Bad leads cost more than just the price of the lead itself" — they carry TCPA exposure, wasted agent hours, and regulatory scrutiny from improper sourcing, according to industry analysis.

Before you hand over a dollar, put every vendor through the same three-part screen: sourcing, consent, and replacement policy. Ask where the leads originate, what opt-in process produced them, and what happens when a lead is disconnected or outside your target county. If the vendor cannot produce permission records, walk away — compliance guidance notes CMS is actively cracking down on Medicare advertising, and "I didn't know where the list came from" is not a defense.

DeCourcy's advice is blunt: "Your growth strategy shouldn't outpace your compliance strategy." That means due diligence into vendors' methods is non-negotiable, as the same InsuranceNewsNet report emphasizes. Vendors should document lead sourcing, opt-in flows, and data privacy protocols before you sign anything.

Run a small test campaign — and read the right numbers. A pilot of a few hundred leads tells you more than any sales deck. Track three metrics:

• Contact rate — how many leads you actually reach; a low rate often signals stale or recycled data.
• Qualification rate — how many contacts match your ideal profile, such as beneficiaries affected by plan terminations.
• Cost per acquisition (CPA) — total spend divided by closed deals. If $5,000 in leads yields 10 closings, your CPA is $500.

DeCourcy is adamant on this last point: "I relentlessly focus on this number." Cost per lead is a vendor's favorite metric; CPA is yours. This matters especially now, with carrier operating margins swinging from +3.9% to –1.1% year over year, squeezing what agents and agencies can afford to spend on acquisition.

The timing makes discipline even more valuable. Roughly 2 million MA enrollees — 7% of the market, versus under 2% in a typical year — need new coverage for PY2025 due to plan terminations and county exits, per ATI Advisory data. A vendor who can target that displaced population with clean permission records is worth far more than a cheaper list with none.

This is exactly the approach My AI Call Center builds into its "Plan My Campaign" review: list source and consent records are checked before launch, bought lists without clear permission records are flagged or declined, and the full campaign cost is quoted up front with one clear goal. Whether you work with us or anyone else, demand the same standard — a full cost picture and a consent review before a single call is made.